By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker today reported a 14 percent increase in total revenues for the fourth quarter of 2010 compared to the previous year, as scientific instruments revenues rose 13 percent.

For the three months ended Dec. 31, 2010, Bruker reported revenues of $416.1 million, compared to $366.4 million a year ago and outpacing analyst estimates of $396.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.